From the NYTimes: The psychedelic revolution Is coming, and psychiatry may never be the same.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.